vs
RHYTHM PHARMACEUTICALS, INC.（RYTM）与SOUTHERN FIRST BANCSHARES INC（SFST）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是SOUTHERN FIRST BANCSHARES INC的1.9倍（$60.1M vs $31.8M），RHYTHM PHARMACEUTICALS, INC.同比增速更快（83.8% vs 26.1%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs 22.2%）
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
第一社区银行股份公司是一家美国银行控股公司，为弗吉尼亚州布卢菲尔德第一社区银行的母公司。截至2012年，该公司旗下银行在弗吉尼亚、西弗吉尼亚和北卡罗来纳共设有45个网点，另有2个网点以人民社区银行名义在田纳西州运营，截至2023年4月，公司总资产达36亿美元。
RYTM vs SFST — 直观对比
营收规模更大
RYTM
是对方的1.9倍
$31.8M
营收增速更快
RYTM
高出57.7%
26.1%
两年增速更快
RYTM
近两年复合增速
22.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $60.1M | $31.8M |
| 净利润 | $-55.6M | — |
| 毛利率 | 88.1% | — |
| 营业利润率 | -87.1% | 40.1% |
| 净利率 | -92.6% | — |
| 营收同比 | 83.8% | 26.1% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.83 | $1.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RYTMSFST
| Q1 26 | $60.1M | — | ||
| Q4 25 | $57.3M | $31.8M | ||
| Q3 25 | $51.3M | $31.1M | ||
| Q2 25 | $48.5M | $28.6M | ||
| Q1 25 | $32.7M | $26.5M | ||
| Q4 24 | $41.8M | $25.2M | ||
| Q3 24 | $33.3M | $23.8M | ||
| Q2 24 | $29.1M | $23.1M |
净利润RYTMSFST
| Q1 26 | $-55.6M | — | ||
| Q4 25 | $-47.5M | — | ||
| Q3 25 | $-52.9M | $8.7M | ||
| Q2 25 | $-46.6M | $6.6M | ||
| Q1 25 | $-49.5M | $5.3M | ||
| Q4 24 | $-43.3M | — | ||
| Q3 24 | $-43.6M | $4.4M | ||
| Q2 24 | $-32.3M | $3.0M |
毛利率RYTMSFST
| Q1 26 | 88.1% | — | ||
| Q4 25 | 91.6% | — | ||
| Q3 25 | 89.3% | — | ||
| Q2 25 | 88.6% | — | ||
| Q1 25 | 88.8% | — | ||
| Q4 24 | 90.9% | — | ||
| Q3 24 | 88.5% | — | ||
| Q2 24 | 89.9% | — |
营业利润率RYTMSFST
| Q1 26 | -87.1% | — | ||
| Q4 25 | -82.2% | 40.1% | ||
| Q3 25 | -102.6% | 36.4% | ||
| Q2 25 | -93.4% | 30.0% | ||
| Q1 25 | -143.7% | 26.1% | ||
| Q4 24 | -98.6% | 27.3% | ||
| Q3 24 | -132.0% | 24.1% | ||
| Q2 24 | -139.2% | 17.0% |
净利率RYTMSFST
| Q1 26 | -92.6% | — | ||
| Q4 25 | -83.0% | — | ||
| Q3 25 | -103.1% | 27.8% | ||
| Q2 25 | -96.1% | 23.0% | ||
| Q1 25 | -151.4% | 19.9% | ||
| Q4 24 | -103.6% | — | ||
| Q3 24 | -131.2% | 18.4% | ||
| Q2 24 | -110.9% | 13.0% |
每股收益（稀释后）RYTMSFST
| Q1 26 | $-0.83 | — | ||
| Q4 25 | $-0.73 | $1.19 | ||
| Q3 25 | $-0.82 | $1.07 | ||
| Q2 25 | $-0.75 | $0.81 | ||
| Q1 25 | $-0.81 | $0.65 | ||
| Q4 24 | $-0.71 | $0.69 | ||
| Q3 24 | $-0.73 | $0.54 | ||
| Q2 24 | $-0.55 | $0.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $340.6M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $122.9M | $368.7M |
| 总资产 | $442.3M | $4.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RYTMSFST
| Q1 26 | $340.6M | — | ||
| Q4 25 | $388.9M | — | ||
| Q3 25 | $416.1M | — | ||
| Q2 25 | $291.0M | — | ||
| Q1 25 | $314.5M | — | ||
| Q4 24 | $320.6M | — | ||
| Q3 24 | $298.4M | — | ||
| Q2 24 | $319.1M | — |
股东权益RYTMSFST
| Q1 26 | $122.9M | — | ||
| Q4 25 | $139.1M | $368.7M | ||
| Q3 25 | $148.8M | $356.3M | ||
| Q2 25 | $-11.9M | $345.5M | ||
| Q1 25 | $18.9M | $337.6M | ||
| Q4 24 | $21.7M | $330.4M | ||
| Q3 24 | $11.2M | $326.5M | ||
| Q2 24 | $39.3M | $318.7M |
总资产RYTMSFST
| Q1 26 | $442.3M | — | ||
| Q4 25 | $480.2M | $4.4B | ||
| Q3 25 | $506.9M | $4.4B | ||
| Q2 25 | $372.7M | $4.3B | ||
| Q1 25 | $386.7M | $4.3B | ||
| Q4 24 | $392.3M | $4.1B | ||
| Q3 24 | $363.6M | $4.2B | ||
| Q2 24 | $381.8M | $4.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $30.5M |
| 自由现金流经营现金流 - 资本支出 | — | $29.9M |
| 自由现金流率自由现金流/营收 | — | 93.8% |
| 资本支出强度资本支出/营收 | — | 1.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $62.1M |
8季度趋势，按日历期对齐
经营现金流RYTMSFST
| Q1 26 | — | — | ||
| Q4 25 | $-25.4M | $30.5M | ||
| Q3 25 | $-26.6M | $14.5M | ||
| Q2 25 | $-23.3M | $10.5M | ||
| Q1 25 | $-40.4M | $7.6M | ||
| Q4 24 | $-18.8M | $25.6M | ||
| Q3 24 | $-25.2M | $26.3M | ||
| Q2 24 | $-29.1M | $4.0M |
自由现金流RYTMSFST
| Q1 26 | — | — | ||
| Q4 25 | — | $29.9M | ||
| Q3 25 | — | $14.4M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $7.4M | ||
| Q4 24 | — | $24.8M | ||
| Q3 24 | — | $26.1M | ||
| Q2 24 | — | $3.9M |
自由现金流率RYTMSFST
| Q1 26 | — | — | ||
| Q4 25 | — | 93.8% | ||
| Q3 25 | — | 46.3% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 28.1% | ||
| Q4 24 | — | 98.2% | ||
| Q3 24 | — | 110.0% | ||
| Q2 24 | — | 16.8% |
资本支出强度RYTMSFST
| Q1 26 | — | — | ||
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.4% |
现金转化率RYTMSFST
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.67× | ||
| Q2 25 | — | 1.59× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.01× | ||
| Q2 24 | — | 1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
